Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.
Access our Antimicrobial Stewardship Programme Resource Pack
Access AMS resources
Access real-time stock monitoring, helpful information and videos about our supply chain, plus a range of training resources.
Access SMART Hub
Access disease awareness downloadable resources
** This is an optional area where footnotes can live.
Listen to experts in a series of short videos present data on β-lactam/β-lactamase inhibitors, share their clinical experience using ZAVICEFTA and its use though a patient case.
Also gain access to webinars and recorded sessions of previous meetings available to view on demand
Follow the link to learn about out upcoming meetings and online webinars event - dates, location and agendas.
cUTI, complicated urinary tract infection, cIAI, complicated intra-abdominal infection; HAP, hospital-acquired pneumonia; VAP, ventilator-associated pneumonia; MDR, multi-drug resistant; BL/BLI, β-lactam/β-lactamase inhibitors; AMR, Antimicrobial Resistance; AMS, Antimicrobial Stewardship
Zavicefta (ceftazidime and avibactam) 2g/0.5 g Powder for Concentrate for Solution for Infusion
View Phase III trial
View safety profile
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020